CClinicalTrials.gg
CompletedNCT05943769Updated Jul 13, 2023

The Impact of Root End Filling Material Type and the Application of Bone Graft on Healing of Periapical Tissues After Endodontic Microsurgery (A Clinical Randomized Controlled Trial)

An interventional study of Apical microsurgery in Periapical Diseases and Periapical Cyst, sponsored by Ain Shams University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-13.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 6 months after the study started (first participant enrolled Jan 2020, registered Jul 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
20 Years to 45 Years
Sex
All
01

Study summary

The goal of this triple blinded randomized clinical trial is to evaluate the effect of combining different bioactive root end filling materials with composite bone graft (xenogeneic mixed with autogenous bone fragments) on the healing process of periapical tissues after endodontic micro-surgery procedure on patients with small to moderate sized lesions. The main questions it aims to answer are:

Will the use of Totalfill in Endodontic surgeries show comparable results to the gold standard MTA? Will the addition of composite bone graft (Xenogenic and Autogenous) affect the healing of small to moderate sized lesions? Is there any interaction between composite bone graft and different bioactive root-end filling materials? Participants were allocated to 4 different groups according to the root-end filling material used with or without bone graft.

Reseachers compared between MTA only group, Totalfill only group, MTA with bone group, and Totalfill with bone group to evaluate healing of the periapical lesion using CBCT after 12 months follow up period.

02

Conditions studied

  • Periapical Diseases
  • Periapical Cyst

Browse trials for

Keywords

  • Apicoectomy
  • Bone graft
  • Endodontic surgery
  • MTA
  • TotalFill
  • Apical lesions
03

In context

Periapical Diseases

44 studies on the registry are indexed under Periapical Diseases; 12 are open to participants now.

This study's enrollment of 56 is close to the median of 60 across 35 interventional studies indexed under Periapical Diseases.

Browse Periapical Diseases studies →

Lead sponsor

Ain Shams University is the lead sponsor of 1,876 studies on the registry; 423 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

All patients must be medically free from any systemic disease that can affect bone healing.

Age range of the patient should be between 20 - 45 years old. All patients must have good oral hygiene. The size of the radiolucent area is of small-moderate size (up to 3 cm in highest diameter at any axis in CBCT), related to a single rooted maxillary tooth.

Periradicular disease in a root-filled tooth where orthograde root canal treatment options has failed,

Exclusion criteria

Exclusion Criteria:

Patient with systemic disease that may affect bone healing. Patients above 45 years or patients below 20 years. Patients with very poor oral hygiene. Teeth presenting with apico-marginal defects or teeth with periodontal disease (periodontal pockets and/or mobility).

Surgery after previous endodontic surgery (re-surgery cases), root resections and amputations, cases presenting with root fractures.

Patients with history of allergies to any of the medications to be used during or after the surgery.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    MTA

    Root end filling material is MTA without bone graft in the defect.

    Procedure: Apical microsurgery

  • Experimental
    TotalFill

    Root end filling material is TotalFill without bone graft in the defect.

    Procedure: Apical microsurgery

  • Experimental
    MTA & bone

    Root end filling material is MTA with the addition of composite bone graft in the defect.

    Procedure: Apical microsurgery

  • Experimental
    TotalFill & bone

    Root end filling material is TotalFill with the addition of composite bone graft in the defect.

    Procedure: Apical microsurgery

Interventions

  • ProcedureApical microsurgery

    inoculation of the periapical or the periradicular lesion with the sectioning of the apical 3mm of the root followed by root-end cavity preparation and retro-filling with the MTA or TotalFill with or without composite bone grafting according to patient allocation.

    Also known as: apicoectomy

06

What researchers measure

Primary outcomes

  1. Healing

    Assessing healing using CBCT

    Time frame: 12 months

07

Study locations

1 site
  • Ain Shams univetsity
    Cairo, 11566, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05943769
Lead sponsor
Ain Shams University
Responsible party
Sponsor
First posted
Jul 13, 2023
Start date
Jan 1, 2020
Primary completion
Aug 20, 2021
Completion
Oct 30, 2022
Last update
Jul 13, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion